Best Cannabis Regulation Updates Podcasts (2025)

1
Richie Proud on the iAnthus Turnaround: Why Selling Arizona Fueled Core-Market Growth 55:05

22h ago55:05

55:05

What if the smartest growth move is cutting—on purpose? Turnarounds aren’t financial stories—they’re operational ones. Growth-at-all-costs is out. The new playbook: prune non-core assets, concentrate resources in high-return states, and speed the path from cultivation to checkout. This week we sit down with Richie Proud, CEO of iAnthus, to discuss:…

1
Regulating Our Emotions as Parents with Alissa Jerud, PhD 1:14:43

3d ago1:14:43

1:14:43

Parenting brings love, joy and plenty of emotional challenges. In this episode, clinical psychologist Dr. Alissa Jerud explores how parents can better understand and regulate their emotions instead of getting stuck in cycles of frustration, anxiety, or control. Drawing on exposure therapy, DBT skills, and her Emotion-Savvy Parenting approach, Dr. J…

1
Secrets Behind Failed Cannabis Builds: Where Every Team Needs to Look Now ft. David Fettner 49:36

8d ago49:36

49:36

Most cannabis facilities fail before the first wall goes up. Most assume it’s because of money — but they’re wrong. It’s because no one asked the right questions. The question you need to ask now is: Where should we be looking to set ourselves up for long-term success? Asking the right questions is critical — because decisions made for today can be…

1
The ROI of Pre-Roll Automation: Scaling Quality, Reducing Labor, and Hitting 20K+ a Day ft. Shahar Yamay 39:00

15d ago39:00

39:00

Every investment is just an ROI calculator. Automation feels risky—until you run the numbers. It doesn’t kill craftsmanship—it scales it. Growing your pre-roll category usually means balancing sales growth with hand-filling teams to maintain quality. But what if you could do both? What if you could leverage best-in-class automation to hit your numb…

1
Moving Fast, Staying Safe: What FIs Need to Know About Stablecoins and RTP 33:35

15d ago33:35

33:35

Join us for an in-depth conversation on the topic of real-time payments, specifically the introduction of Stablecoin. In this conversation, we will discuss Definitions and differences of RTP vs Stablecoin Benefits and risks associated with both Regulatory concerns What financial institutions need to do to prepare for the more general adoption of th…

1
Financially motivated sextortion: Old crime, new twist 34:35

21d ago34:35

34:35

Sadly, extortion and sexual exploitation are nothing new to the world, but today, we discuss a new twist to these old crimes. Learn how criminal organizations are preying on the younger generation and ways you can identify these crimes. Our moderator, Terri Luttrell, will steer the conversation with Alison Jimenez, our expert, to provide everyone w…

1
Keep Your Eye on Ohio: Why California’s Failures Are Michigan’s Success, and the Global Cannabis Landscape ft. Hirsh Jain 56:44

22d ago56:44

56:44

What’s the real goal of a legal cannabis market? If it’s to replace the illicit market, create safe access, and drive tax revenue—then why is California, the world’s 4th largest economy, failing while Michigan is thriving? Despite California’s size and cultural dominance, cannabis sales are shrinking, cities are refusing to opt in, and the illicit …

1
Psychodynamic Psychopharmacology: Insights from Dr. David Mintz 1:14:52

27d ago1:14:52

1:14:52

In this episode, I engage in a shared-interest conversation with Dr. David Mintz, a psychiatrist with over 30 years of experience at the Austen Riggs Center, about his book Psychodynamic Psychopharmacology: Caring for the Treatment-Resistant Patient. Mintz explores the integration of psychodynamic principles into medication prescribing, emphasizing…

1
The Cannabis Titanic: The Reset Ahead, Matt Karnes on What the Numbers Say 43:04

29d ago43:04

43:04

Debt is coming due — and we’re approaching a point of no return. At this stage, it’s not if there will be fallout — it’s who survives it. The surface-level view of the cannabis industry hides deep financial issues that only become clear when you dig into the numbers. And that’s exactly what Matt Karnes has been doing for years. From cash flow strai…

1
Organigram’s Competitive Edge: Paolo De Luca on BAT, M&A Strategy, and the Cannabis Long Game 54:43

1M ago54:43

54:43

Built to last. That’s not just a slogan — it’s a strategy. In an industry driven by short-term survival, the cannabis space often feels like a rollercoaster. Financial pressures and market volatility push companies to chase quarters instead of building moats. But what if you could play the long game? What if you could invest in domain knowledge, de…

1
The Michelin-Star Experience? Gibran Washington on What Customers Actually Want 49:52

1M ago49:52

49:52

What if buying cannabis felt more like a Michelin-star dining experience than a traditional retail transaction? Where the staff doesn’t just sell—they guide, educate, and tailor every recommendation to how you want to feel. No guessing. Just clarity, confidence, and trust—rooted in science-backed evidence. That’s the vision behind Ethos Cannabis. W…

1
AI in Cannabis Commerce Is Here — But Jane’s Doing It Their Way with Socrates Rosenfeld 50:02

2M ago50:02

50:02

AI is reshaping every corner of commerce — and in cannabis, where the pace is chaotic and change can be difficult, thoughtful integration is even harder. We’re in the middle of a digital transformation as profound as the rise of the internet. In a space where “speed and size” used to win, the new game is endurance. Because to finish first, you have…

1
Catatonia in Children and Teens 53:53

2M ago53:53

53:53

Catatonia in children and teens is underdiagnosed, frequently misunderstood, and potentially fatal if left untreated. In this episode, Dr. David Puder and Dr. Annabel Kuhn interview Dr. Joshua Ryan Smith—child and adolescent psychiatrist and division director at Vanderbilt University—to explore the essential clinical skills and medical knowledge ne…

1
Trump, Texas SB3 & the Rescheduling Timeline: Jim Higdon on What Comes Next 48:46

2M ago48:46

48:46

Prohibition is dead — and Texas just proved it. The recent SB3 vote signaled the start of something much bigger. While hemp and cannabis operate in very different styles, both are ultimately pushing toward the same goal: a sensible framework for a one-plant solution. The how? I’ll leave that to people way smarter than me. But the genie is NOT going…

1
The Hidden Weakness in Most Cannabis Operations — What We Heard at Benzinga 43:41

2M ago43:41

43:41

The cannabis shakeout isn’t coming. It’s already here. Operators are bleeding, investors are disappearing, and the old playbook is falling apart. After Benzinga, one thing’s clear: the winners will be the ones who specialize, control every cost, and have visibility into every part of their business in real time. What happens when you pull back the …

1
The Bear: Trauma, Personality, and Attachment with Dr. Eric Bender and Dr. David Puder 1:09:03

2M ago1:09:03

1:09:03

In this episode, Dr. David Puder is joined by psychiatrist Dr. Eric Bender to explore the psychological depth of the Emmy Award-winning show, The Bear (FX). Through a psychodynamic lens, they examine Carmy’s character—his trauma, complex PTSD, obsessive-compulsive personality traits, and avoidant attachment style. They also break down the borderlin…

1
Storytelling Is the Future of Cannabis IR ft Jesse Redmond 54:47

2M ago54:47

54:47

What if the most powerful investor pitch wasn’t a deck or a breakdown of earnings—but a story? Now, the idea of seeds in the ground to thriving plants is a tangible experience—one that finally captures the real narrative. Because in cannabis, the financials don’t always tell the full story. This week, we sit down with Jesse Redmond, Head of Investo…

1
Tariffs, technology, and trust: Duncan Taylor on the forces shaping community banking 30:51

2M ago30:51

30:51

In this episode of Ahead of the Curve, we discuss the ripple effects of global trade, regulatory shifts, and advancing fraud threats with Duncan Taylor, SVP and Chief Operating Officer of the Washington Bankers Association. Tune in as we explore: How tariffs and international trade tensions are impacting regional and agricultural banks What communi…

1
Fix the Process: Real Cannabis Manufacturing Tools & Optimization Techniques ft.: Murphy Murri 56:48

3M ago56:48

56:48

Most cannabis operators are reactive—drowning in checklists, flooded with data, and still missing the point. Compliance gets all the attention, while real operational signals—like handling variability and shifting process conditions—lead to execution gaps and reactive decision-making. Extraction process optimization is tricky, but when the actual r…

1
Brett Puffenbarger: The Future of Cannabis Will Look Like This… and Yes, It Will Shock You 54:49

3M ago54:49

54:49

What if we told you the future of cannabis looks less like dispensaries... and more like the milk aisle? Everyone’s chasing growth, market share, and the next hot product — but few are asking the deeper question: What will the cannabis industry actually become? While cannabis is certainly disruptive, its future likely follows a few predictable path…

1
Depressive Personality Style with Jonathan Shedler 1:53:38

3M ago1:53:38

1:53:38

Dr. David Puder and psychologist Dr. Jonathan Shedler explore depressive personality style—how it differs from clinical depression and why it often goes unrecognized. Through a detailed role play, they demonstrate how self-criticism, unconscious guilt, emotional deprivation, and suppressed anger emerge in therapy. They discuss: How depressive perso…

1
No Exits, No Capital, No Bullsh*t: Seth Yakatan on Cannabis Reality 45:37

3M ago45:37

45:37

There’s no exits. There’s no cash. There’s no buyers. So what do you do? Batten down the hatches. Crush your market. Squeeze out the little guys who can’t compete — and wait. This week, Seth Yakatan returns to discuss the following: • How he’s seeing the board • Why cannabis can’t hit reset like other industries • What operators need to do right no…

1
Where’s the Cash? Visibility, Inventory & Profitable Growth with Tyler Nielsen 54:40

3M ago54:40

54:40

"Cash strapped" might be the most heard phrase in the cannabis industry right now. So… where’s the cash? Without disciplined forecasting and visibility into true costs, growth is meaningless. Most companies aren’t failing from bad ideas — they’re failing in execution. That’s where cash leaks into missed forecasts, bloated inventory, and lost opport…

1
Why the Industry’s Premier Brands Choose The Flowery — and What’s Coming Next in New York & Florida ft. Ilya Shmidt 45:00

4M ago45:00

45:00

Florida and New York are massive markets — but they’re still early. Everyone’s fighting for attention, trust, and long-term positioning. So how did The Flowery rise to the top and become the go-to partner for the industry’s premier brands? 710 Labs. Wizard Trees. Preferred Gardens. Doja Pak the list goes on. These brands are some of the most sought…

1
Cannabis and Psychosis: The Link Between THC Use and Mental Health Risks 1:17:46

4M ago1:17:46

1:17:46

Dive deep into the connection between cannabis (THC) and psychosis in this enlightening episode with Dr. David Puder. Explore cutting-edge research on how cannabis impacts neurodevelopment, particularly during adolescence, and discover genetic and environmental factors that can amplify psychosis risk. This episode provides valuable insights into re…

1
Bank spotlight: How self-serve technology and financial literacy programming have paid off for BankFive 23:03

4M ago23:03

23:03

In this episode of Ahead of the Curve, you'll hear innovative ideas on financial literacy programs and leveraging technology for better customer service from Anne Tangen, President and CEO of BankFive. Tune in as we discuss: How to engage customers in learning about improving their credit The role of financial literacy in getting the right loan pro…

1
Big Tobacco Is Moving on Cannabis, the Global Strategy Is Unfolding, and Deepak Anand Reveals Where’s Next 48:42

4M ago48:42

48:42

Big Tobacco knows cigarettes are dead. They’re sitting on cash, looking for growth — and cannabis is the obvious move. They’re no longer silently watching from the sidelines. They’re investing, expanding — some through public acquisitions, others through quieter plays. But one thing is clear: it’s no secret anymore. Big Tobacco is here, leveraging …

1
Transference Focused Psychotherapy & Personality Disorders with Dr. Otto Kernberg 1:28:20

4M ago1:28:20

1:28:20

In this episode, Dr. Otto Kernberg, a pioneer of Transference-Focused Psychotherapy (TFP), discusses personality disorders through a psychoanalytic lens. Explore key insights into Borderline Personality Disorder (BPD), identity diffusion, primitive defense mechanisms such as splitting and projective identification, and the complexities of narcissis…

1
Secrets Behind World-Class Extraction: How 1% Add Millions ft. Micah Anderson 59:42

4M ago59:42

59:42

Specialization is coming — and surviving will mean doing one thing better than anyone else. But that’s only the beginning. Getting there takes a relentless growth mindset: an obsession with stacking small operational wins — data, tech, genetics, process — to create massive separation over time. Extraction isn’t simple. And in a world of margin comp…

1
Creatine and Mental Health 1:26:53

4M ago1:26:53

1:26:53

In this episode of Psychiatry & Psychotherapy, Dr. David Puder hosts a deep dive with experts Nicholas Fabiano, MD, Brandon Luu, MD, Joshua Mangunsong, MS3, and Liam Browning, MS4 into the exciting potential of creatine supplementation for mental health and cognitive enhancement. They explore cutting-edge research on how creatine can improve mood d…

1
If You’re Chasing Invoices in Cannabis, Listen to This ft. Brett Gelfand 50:18

4M ago50:18

50:18

You produced the product. They said they needed terms — “as soon as it sells, we’ll pay.” But the days kept going by… and nothing came in. In cannabis, collections are brutally difficult. With limited banking and tight cash flow, cash is king. So how do you know who’s trustworthy? Who’s a repeat offender? And where do you even go to collect? Sadly,…

1
Ketogenic Diet Review and Update with Dr. Matt Bernstein 1:39:45

4M ago1:39:45

1:39:45

Explore the transformative potential of the ketogenic diet for mental health with expert Dr. Matt Bernstein, a pioneer in metabolic psychiatry. Learn how targeting metabolic dysfunction can profoundly improve psychiatric outcomes in bipolar disorder, schizophrenia, depression, and epilepsy, with fewer side effects than traditional treatments. Disco…

1
How Ayr Wellness Is Resizing for Reality — What Operational Efficiency Really Means ft. George DeNardo 44:30

4M ago44:30

44:30

It’s not about planting flags anymore. It’s about profitability. As the cannabis industry shifts from rapid growth at all costs to operational precision, hard decisions are being made. Which assets are sized properly? Where can we build a well-rounded, potentially profitable business given the realities of today’s market? And how do we make the rig…

1
Why Cannabis Companies Must Face Reality, Make Hard Choices, and Follow the Data ft. AnnaRae Grabstein 48:29

5M ago48:29

48:29

While it feels like progress isn’t happening — and that may be true at the federal level — inside the industry, it’s a completely different story. The financial model you built, the regulatory category you operate in, the market dynamics, the consumer behavior — every one of those variables is in motion. Constantly evolving. And new competitors are…

1
Clozapine & Schizophrenia with Michael Cummings, MD 1:42:06

5M ago1:42:06

1:42:06

Join Dr. David Puder and expert psychopharmacologist Dr. Michael Cummings in a detailed discussion on Clozapine, the gold standard medication for treatment-resistant schizophrenia. They explore recent significant updates, including the removal of the Clozapine REMS program, which simplifies patient care and medication management. This episode cover…

1
How Leafwell is Disrupting Healthcare: The Data Doctors Can’t Ignore ft. Emily Fisher & Dr June Chin 45:52

5M ago45:52

45:52

Can cannabis be the key to lowering healthcare costs and improving patient outcomes? Impossible, right? Think again. Leafwell has analyzed millions of data points and uncovered staggering, undeniable results—cannabis patients experience fewer ER visits, reduced prescription drug use, and better health outcomes compared to non-users. These findings …

1
The Hard Thing About Hard Things: A Melody of Grit & Fortitude ft. Christina Betancourt Johnson 51:34

5M ago51:34

51:34

“It’s this crazy melody of things constantly happening, and you need an incredible degree of grit and fortitude. Even the best-prepared individuals with meticulous plans have to throw them up in the air like confetti. It’s an intangible feeling—until you get into it, you really don’t know.” This quote from Christina Betancourt Johnson perfectly cap…

1
The Serotonin Hypothesis: Controversies and Nuance with Awais Aftab, MD 1:16:50

5M ago1:16:50

1:16:50

Is depression really caused by low serotonin? Dr. Awais Aftab joins Dr. David Puder to explore the serotonin hypothesis, antidepressant efficacy, and the controversies surrounding SSRIs. They dive into the history of the serotonin deficiency theory, key research on antidepressants vs. placebo, and how neuroplasticity, psychotherapy, and lifestyle c…

1
Balancing AI capabilities and human expertise in loan review and beyond 15:36

5M ago15:36

15:36

In this episode of Ahead of the Curve, we explore how Artificial Intelligence is transforming the loan review process, making it more efficient, accurate, and compliant—while ensuring that human expertise remains essential. Joining us is Steve Wert, Vice President of DiCom Loan Review Solutions at Abrigo. With over 20 years of experience in market …

Podcasts Worth a Listen

Cannabis Regulation Updates Podcasts

Podcasts Worth a Listen

Quick Reference Guide